Decitabine versus 5-azacitidine for the treatment of myelodysplastic syndrome: adjusted indirect meta-analysis

被引：14

作者：

Kumar, Ambuj ^{[1
,2
,3
]}

List, Alan F. ^{[1
,2
,3
]}

Hozo, Iztok

Komrokji, Rami ^{[1
,2
,3
]}

Djulbegovic, Benjamin ^{[1
,2
,3
]}

机构：

[1] Univ S Florida, Moffitt Canc Ctr, Tampa, FL 33642 USA

[2] Univ S Florida, Res Inst, Tampa, FL 33642 USA

[3] Univ S Florida, Dept Oncol Sci, Tampa, FL 33642 USA

来源：

HAEMATOLOGICA-THE HEMATOLOGY JOURNAL | 2010年 / 95卷 / 02期

关键词：

myelodysplastic syndrome; hypomethylating agents; 5-azacitidine; decitabine;

D O I：

10.3324/haematol.2009.017764

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：340 / 342

页数：3

共 11 条

[1] The results of direct and indirect treatment comparisons in meta-analysis of randomized controlled trials [J].

Bucher, HC ;

Guyatt, GH ;

Griffith, LE ;

Walter, SD .

JOURNAL OF CLINICAL EPIDEMIOLOGY, 1997, 50 (06) :683-691

[2]

Glenny AM, 2005, HEALTH TECHNOL ASSES, V9, P1

[3] 5-azacitidine prolongs overall survival in patients with myelodysplastic syndrome - systematic review and meta-analysis (Reply to Kumar et al. and to Herbst et al.) [J].

Gurion, Ronit ;

Vidal, Liat ;

Gafter-Gvili, Anat ;

Belnik, Yulia ;

Yeshurun, Moshe ;

Raanani, Pia ;

Shpilberg, Ofer .

HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2010, 95 (02) :343-344

[4] Decitabine improves patient outcomes in myelodysplastic syndromes - Resuits of a Phase III randomized study [J].

Kantarjian, H ;

Issa, JPJ ;

Rosenfeld, CS ;

Bennett, JM ;

Albitar, M ;

DiPersio, J ;

Klimek, V ;

Slack, J ;

de Castro, C ;

Ravandi, F ;

Helmer, R ;

Shen, LL ;

Nimer, SD ;

Leavitt, R ;

Raza, A ;

Saba, H .

CANCER, 2006, 106 (08) :1794-1803

[5]

KUMAR A, 2008, ASH ANN M 2008 NOV 1, V112, P3632

[6]

KUMAR A, 2008, 14 C EUR SOC HEM JUN

[7] Network meta-analysis for indirect treatment comparisons [J].

Lumley, T .

STATISTICS IN MEDICINE, 2002, 21 (16) :2313-2324

[8]

Parmar MKB, 1998, STAT MED, V17, P2815, DOI 10.1002/(SICI)1097-0258(19981230)17:24<2815::AID-SIM110>3.0.CO

[9]

2-8

[10] Randomized controlled trial of azacitidine in patients with the myelodysplastic syndrome: A study of the cancer and leukemia group B [J].

Silverman, LR ;

Demakos, EP ;

Peterson, BL ;

Kornblith, AB ;

Holland, JC ;

Odchimar-Reissig, R ;

Stone, RM ;

Nelson, D ;

Powell, BL ;

DeCastro, CM ;

Ellerton, J ;

Larson, RA ;

Schiffer, CA ;

Holland, JF .

JOURNAL OF CLINICAL ONCOLOGY, 2002, 20 (10) :2429-2440

← 1 2 →